Thiamine Metabolism Dysfunction Syndrome 4 disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Thiamine Metabolism Dysfunction Syndrome 4

MalaCards integrated aliases for Thiamine Metabolism Dysfunction Syndrome 4:

Name: Thiamine Metabolism Dysfunction Syndrome 4 ⁵⁷ ¹³ ⁷³

Striatal Necrosis, Bilateral, and Progressive Polyneuropathy ⁵⁷ ²⁹ ⁶

Bilateral Striatal Degeneration and Progressive Polyneuropathy ⁵⁷ ⁷⁵

Thmd4 ⁵⁷ ⁷⁵

Thiamine Metabolism Dysfunction Syndrome 4, Bilateral Striatal Degeneration and Progressive Polyneuropathy Type ⁷⁵

Progressive Polyneuropathy with Bilateral Striatal Necrosis ⁵⁹

Striatal Necrosis, Bilateral and Progressive Polyneuropathy ⁷⁵

Thiamine Metabolism Dysfunction Syndrome, Type 4 ⁴⁰

Characteristics:

Orphanet epidemiological data:

⁵⁹

progressive polyneuropathy with bilateral striatal necrosis
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Childhood;

OMIM:

⁵⁷

Inheritance:
autosomal recessive

Miscellaneous:
onset of acute encephalopathic attacks in childhood (3 to 7 years)
onset usually associated with febrile illness
full recovery after attacks
onset of chronic progressive polyneuropathy in late childhood
one family has been reported (as of january 2011)

HPO:

³²

thiamine metabolism dysfunction syndrome 4:
Inheritance autosomal recessive inheritance

Classifications:

MalaCards categories:
Global: Genetic diseases Metabolic diseases Rare diseases
Anatomical: Neuronal diseases

See all MalaCards categories (disease lists)

Orphanet: ⁵⁹

Rare neurological diseases

Inborn errors of metabolism

External Ids:

OMIM ⁵⁷ 613710

Orphanet ⁵⁹ ORPHA217396

MedGen ⁴² C3150973

MeSH ⁴⁴ D001480

SNOMED-CT via HPO ⁶⁹ 258211005 214264003 405946002 more

UMLS ⁷³ C3150973

Sources

Summaries for Thiamine Metabolism Dysfunction Syndrome 4

OMIM : ⁵⁷ Thiamine metabolism dysfunction syndrome-4 is an autosomal recessive metabolic disorder characterized by childhood onset of episodic encephalopathy, often associated with a febrile illness, and causing transient neurologic dysfunction. Most patients recover fully, but some may have mild residual weakness. Affected individuals also develop a slowly progressive axonal polyneuropathy beginning in childhood. Brain imaging during the acute episodes shows lesions consistent with bilateral striatal degeneration or necrosis (summary by Spiegel et al., 2009). For a discussion of genetic heterogeneity of disorders due to thiamine metabolism dysfunction, see THMD1 (249270). (613710)

MalaCards based summary : Thiamine Metabolism Dysfunction Syndrome 4, is also known as striatal necrosis, bilateral, and progressive polyneuropathy, and has symptoms including lethargy and weakness. An important gene associated with Thiamine Metabolism Dysfunction Syndrome 4 is SLC25A19 (Solute Carrier Family 25 Member 19). Affiliated tissues include brain and skeletal muscle, and related phenotypes are muscle weakness and skeletal muscle atrophy

UniProtKB/Swiss-Prot : ⁷⁵ Thiamine metabolism dysfunction syndrome 4, bilateral striatal degeneration and progressive polyneuropathy type: A disease characterized by recurrent episodes of flaccid paralysis and encephalopathy associated with bilateral striatal necrosis and chronic progressive polyneuropathy.

Sources

Related Diseases for Thiamine Metabolism Dysfunction Syndrome 4

Diseases in the Thiamine Metabolism Dysfunction Syndrome 2 family:

Thiamine Metabolism Dysfunction Syndrome 4

Thiamine Metabolism Dysfunction Syndrome 5

Sources

Symptoms & Phenotypes for Thiamine Metabolism Dysfunction Syndrome 4

Symptoms via clinical synopsis from OMIM:

⁵⁷

Neurologic Central Nervous System:
paralysis
lethargy
weakness
encephalopathic attacks, episodic, associated with infection
difficulty walking and running
more

Skeletal Feet:
foot deformities
pes equinus
forefoot adduction
forefoot supination

Muscle Soft Tissue:
distal muscle weakness due to neuropathy
distal muscle atrophy due to neuropathy

Neurologic Peripheral Nervous System:
hyporeflexia
axonal neuropathy
distal muscle weakness due to neuropathy (lower limbs more affected than upper limbs)
distal muscle atrophy due to neuropathy (lower limbs more affected than upper limbs)

Skeletal:
distal joint contractures, lower limbs

Laboratory Abnormalities:
increased csf lactate during acute episodes

Clinical features from OMIM:

613710

Human phenotypes related to Thiamine Metabolism Dysfunction Syndrome 4:

³² (show all 11)

#	Description	HPO Source Accession
1	muscle weakness ³²	HP:0001324
2	skeletal muscle atrophy ³²	HP:0003202
3	talipes equinovarus ³²	HP:0001762
4	paralysis ³²	HP:0003470
5	difficulty walking ³²	HP:0002355
6	hyporeflexia ³²	HP:0001265
7	lethargy ³²	HP:0001254
8	peripheral axonal neuropathy ³²	HP:0003477
9	polyneuropathy ³²	HP:0001271
10	increased csf lactate ³²	HP:0002490
11	contractures of the joints of the lower limbs ³²	HP:0005750

UMLS symptoms related to Thiamine Metabolism Dysfunction Syndrome 4:

lethargy, weakness

Sources

Drugs & Therapeutics for Thiamine Metabolism Dysfunction Syndrome 4

Search Clinical Trials , NIH Clinical Center for Thiamine Metabolism Dysfunction Syndrome 4

Sources

Genetic Tests for Thiamine Metabolism Dysfunction Syndrome 4

Genetic tests related to Thiamine Metabolism Dysfunction Syndrome 4:

#	Genetic test	Affiliating Genes
1	Striatal Necrosis, Bilateral, and Progressive Polyneuropathy ²⁹	SLC25A19

Sources

Anatomical Context for Thiamine Metabolism Dysfunction Syndrome 4

MalaCards organs/tissues related to Thiamine Metabolism Dysfunction Syndrome 4:

⁴¹

Brain, Skeletal Muscle

Sources

Publications for Thiamine Metabolism Dysfunction Syndrome 4

Sources

Genes for Thiamine Metabolism Dysfunction Syndrome 4

Genes related to Thiamine Metabolism Dysfunction Syndrome 4 (1 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	SLC25A19	Solute Carrier Family 25 Member 19	Protein Coding	1677.82	Molecular basis known ⁵⁷ Pathogenic ⁶ Causative germline mutation ⁵⁹ Causative variation ⁷⁵ Genetic Tests ²⁹ GeneCards inferred via : Disorders Variants (show sections)	19798730

Sources

Variations for Thiamine Metabolism Dysfunction Syndrome 4

UniProtKB/Swiss-Prot genetic disease variations for Thiamine Metabolism Dysfunction Syndrome 4:

⁷⁵

#	Symbol	AA change	Variation ID	SNP ID
1	SLC25A19	p.Gly125Ser	VAR_065125	rs387906944

ClinVar genetic disease variations for Thiamine Metabolism Dysfunction Syndrome 4:

⁶ (show all 12)

#	Gene	Variation	Type	Significance	SNP ID	Assembly	Location
1	SLC25A19	NM_021734.4(SLC25A19): c.373G> A (p.Gly125Ser)	single nucleotide variant	Pathogenic	rs387906944	GRCh37	Chromosome 17, 73279590: 73279590
2	SLC25A19	NM_021734.4(SLC25A19): c.373G> A (p.Gly125Ser)	single nucleotide variant	Pathogenic	rs387906944	GRCh38	Chromosome 17, 75283509: 75283509
3	SLC25A19	NM_021734.4(SLC25A19): c.550G> C (p.Ala184Pro)	single nucleotide variant	Pathogenic	rs769187207	GRCh38	Chromosome 17, 75278245: 75278245
4	SLC25A19	NM_021734.4(SLC25A19): c.550G> C (p.Ala184Pro)	single nucleotide variant	Pathogenic	rs769187207	GRCh37	Chromosome 17, 73274326: 73274326
5	SLC25A19	NM_021734.4(SLC25A19): c.481G> A (p.Ala161Thr)	single nucleotide variant	Pathogenic		GRCh37	Chromosome 17, 73274395: 73274395
6	SLC25A19	NM_021734.4(SLC25A19): c.481G> A (p.Ala161Thr)	single nucleotide variant	Pathogenic		GRCh38	Chromosome 17, 75278314: 75278314
7	SLC25A19	NM_021734.4(SLC25A19): c.454C> A (p.Pro152Thr)	single nucleotide variant	Pathogenic		GRCh37	Chromosome 17, 73279509: 73279509
8	SLC25A19	NM_021734.4(SLC25A19): c.454C> A (p.Pro152Thr)	single nucleotide variant	Pathogenic		GRCh38	Chromosome 17, 75283428: 75283428
9	SLC25A19	NM_021734.4(SLC25A19): c.194C> T (p.Ala65Val)	single nucleotide variant	Pathogenic		GRCh38	Chromosome 17, 75286398: 75286398
10	SLC25A19	NM_021734.4(SLC25A19): c.194C> T (p.Ala65Val)	single nucleotide variant	Pathogenic		GRCh37	Chromosome 17, 73282479: 73282479
11	SLC25A19	NM_021734.4(SLC25A19): c.240A> C (p.Lys80Asn)	single nucleotide variant	Likely pathogenic		GRCh37	Chromosome 17, 73282433: 73282433
12	SLC25A19	NM_021734.4(SLC25A19): c.240A> C (p.Lys80Asn)	single nucleotide variant	Likely pathogenic		GRCh38	Chromosome 17, 75286352: 75286352

Sources

Expression for Thiamine Metabolism Dysfunction Syndrome 4

Search GEO for disease gene expression data for Thiamine Metabolism Dysfunction Syndrome 4.

Sources

Pathways for Thiamine Metabolism Dysfunction Syndrome 4

Sources

GO Terms for Thiamine Metabolism Dysfunction Syndrome 4

Sources

Sources for Thiamine Metabolism Dysfunction Syndrome 4

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia

Thiamine Metabolism Dysfunction Syndrome 4 (THMD4)

Aliases & Classifications for Thiamine Metabolism Dysfunction Syndrome 4

MalaCards integrated aliases for Thiamine Metabolism Dysfunction Syndrome 4:

Characteristics:

Orphanet epidemiological data:

OMIM:

HPO:

Classifications:

External Ids:

Summaries for Thiamine Metabolism Dysfunction Syndrome 4

Related Diseases for Thiamine Metabolism Dysfunction Syndrome 4

Diseases in the Thiamine Metabolism Dysfunction Syndrome 2 family:

Symptoms & Phenotypes for Thiamine Metabolism Dysfunction Syndrome 4

Symptoms via clinical synopsis from OMIM:

Clinical features from OMIM:

Human phenotypes related to Thiamine Metabolism Dysfunction Syndrome 4:

UMLS symptoms related to Thiamine Metabolism Dysfunction Syndrome 4:

Drugs & Therapeutics for Thiamine Metabolism Dysfunction Syndrome 4

Genetic Tests for Thiamine Metabolism Dysfunction Syndrome 4

Genetic tests related to Thiamine Metabolism Dysfunction Syndrome 4:

Anatomical Context for Thiamine Metabolism Dysfunction Syndrome 4

MalaCards organs/tissues related to Thiamine Metabolism Dysfunction Syndrome 4:

Publications for Thiamine Metabolism Dysfunction Syndrome 4

Genes for Thiamine Metabolism Dysfunction Syndrome 4

Genes related to Thiamine Metabolism Dysfunction Syndrome 4 (1 elite genes):

Variations for Thiamine Metabolism Dysfunction Syndrome 4

UniProtKB/Swiss-Prot genetic disease variations for Thiamine Metabolism Dysfunction Syndrome 4:

ClinVar genetic disease variations for Thiamine Metabolism Dysfunction Syndrome 4:

Expression for Thiamine Metabolism Dysfunction Syndrome 4

Pathways for Thiamine Metabolism Dysfunction Syndrome 4

GO Terms for Thiamine Metabolism Dysfunction Syndrome 4

Sources for Thiamine Metabolism Dysfunction Syndrome 4